tbuckley/cabot-search huggingface dataset:
Effects of Nicorandil on Aortic Input Impedance:A Comparative Study With Nitroglycerin
Authors: Masami Fujita, Kenji Takazawa, Nobuhiro Tanaka, Chiharu Ibukiyama
Journal: Circulation (1999)

A study of aortic input impedance was performed to evaluate the effects of nicorandil on the systemic circulation, and the effects were compared with those of nitroglycerin. Sixteen patients with coronary artery disease were divided into 2 age-matched groups. Aortic input impedance was obtained from Fourier analysis of aortic pressure and flow signals at baseline conditions, after intravenous administration of either 4 mg (Group 1) or 8 mg (Group 2) nicorandil, and 20 min after 0.3 mg sublingual nitroglycerin. In Group 1, the first harmonic impedance modulus (Z1, 304+/-140 dyne x s x cm(-5)) and the average of the first to third harmonics (Z1-3, 207+/-99 dyne x s x cm(-5)), indices of wave reflection, significantly decreased (24.4% (p<0.05) and 24.7% (p<0.01), respectively) after nicorandil, and 41.3% (p<0.01) and 33.9% (p<0.01) after nitroglycerin. The effects between the 2 vasodilators were not significantly different. In Group 2, Z1 and Z1-3 (275+/-138 and 196+/-93 dyne x s x cm(-5), respectively) also decreased after administration of nicorandil (28.4% (p<0.01) and 35.9% (p<0.01), respectively), and after administration of nitroglycerin (23.9% (p<0.01) and 28.7% (p<0.01), respectively), without any significant difference between the 2 drugs. Characteristic impedance and total peripheral resistance (R) in both groups remained unchanged except for R after 8 mg nicorandil (from 1830+/-415 to 1433+/-428 dyne x s x cm(-5); p<0.01). Like nitroglycerin, both doses of nicorandil reduced wave reflection. The reduction in R after 8 mg nicorandil is related to decreased tone in the resistance arteries, probably due to potassium channel opener effects.
Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma Patients with Renal Insufficiency: a Single Centre Experience.
Authors: Malgorzata Krawczyk-Kulis, Slawomira Kyrcz-Krzemien, Tomasz Czerw, Monika Zielinska, Grazyna Bober
Journal: Blood (2009)
A Constitutive Increase in Gamma Globin Gene Production during the Erythroid Differentiation of CD34+ Cells from Sickle Cell Disease Patients and Alterations in Cyclic Nucleotide Levels during This Differentiation.
Authors: Carolina Lanaro, Adriana S.S Duarte, Dulcineia M. Albuquerque, Nicola Conran, Sara T.O Saad, Fernando F. Costa
Journal: Blood (2007)
Plasminogen Activator Inhibitor-1 and Vitronectin Levels in Children with Acute Lymphoblastic Leukemia, and Their Relationship with Risk Groups
Authors: Semra Ayduran, Omer Devecioglu, Aysegul Unuvar, Hakan Ekmekci, Zeynep Karakas, Gulyuz Ozturk, Sema Anak, Leyla Agaoglu, Kaan Kavakli
Journal: Blood (2011)
Sensitive In Vivo Detection of Primary T Cells Expressing Membrane-Anchored Gaussia Luciferase for the Study of Adoptive T Cell Immunotherapy in Murine Models of Malignancy.
Authors: Renier J. Brentjens, Elmer Santos, Raymond Yeh, Krista La Perle, Ricardo Toledo-Crow, Yan Nikhamin, Blesida Punzalan, David Entenberg, Iana Aranda, Bleserene Punzalan, Steven Larson, Michel Sadelain
Journal: Blood (2006)
Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections
Authors: Roy W. Beck, Tonya Riddlesworth, Katrina Ruedy, Andrew Ahmann, Richard Bergenstal, Stacie Haller, Craig Kollman, Davida Kruger, Janet B. McGill, William Polonsky, Elena Toschi, Howard Wolpert, David Price
Journal: JAMA (2017)

<h3>Importance</h3> Previous clinical trials showing the benefit of continuous glucose monitoring (CGM) in the management of type 1 diabetes predominantly have included adults using insulin pumps, even though the majority of adults with type 1 diabetes administer insulin by injection. <h3>Objective</h3> To determine the effectiveness of CGM in adults with type 1 diabetes treated with insulin injections. <h3>Design, Setting, and Participants</h3> Randomized clinical trial conducted between October 2014 and May 2016 at 24 endocrinology practices in the United States that included 158 adults with type 1 diabetes who were using multiple daily insulin injections and had hemoglobin A<sub>1c</sub>(HbA<sub>1c</sub>) levels of 7.5% to 9.9%. <h3>Interventions</h3> Random assignment 2:1 to CGM (n = 105) or usual care (control group; n = 53). <h3>Main Outcomes and Measures</h3> Primary outcome measure was the difference in change in central-laboratory–measured HbA<sub>1c</sub>level from baseline to 24 weeks. There were 18 secondary or exploratory end points, of which 15 are reported in this article, including duration of hypoglycemia at less than 70 mg/dL, measured with CGM for 7 days at 12 and 24 weeks. <h3>Results</h3> Among the 158 randomized participants (mean age, 48 years [SD, 13]; 44% women; mean baseline HbA<sub>1c</sub>level, 8.6% [SD, 0.6%]; and median diabetes duration, 19 years [interquartile range, 10-31 years]), 155 (98%) completed the study. In the CGM group, 93% used CGM 6 d/wk or more in month 6. Mean HbA<sub>1c</sub>reduction from baseline was 1.1% at 12 weeks and 1.0% at 24 weeks in the CGM group and 0.5% and 0.4%, respectively, in the control group (repeated-measures model<i>P</i> &lt; .001). At 24 weeks, the adjusted treatment-group difference in mean change in HbA<sub>1c</sub>level from baseline was –0.6% (95% CI, –0.8% to –0.3%;<i>P</i> &lt; .001). Median duration of hypoglycemia at less than &lt;70 mg/dL was 43 min/d (IQR, 27-69) in the CGM group vs 80 min/d (IQR, 36-111) in the control group (<i>P</i> = .002). Severe hypoglycemia events occurred in 2 participants in each group. <h3>Conclusions and Relevance</h3> Among adults with type 1 diabetes who used multiple daily insulin injections, the use of CGM compared with usual care resulted in a greater decrease in HbA<sub>1c</sub>level during 24 weeks. Further research is needed to assess longer-term effectiveness, as well as clinical outcomes and adverse effects. <h3>Trial Registration</h3> clinicaltrials.gov Identifier:NCT02282397
Rituximab Inhibits the PI3K/Akt Survival Pathway In B-NHL Cells Via Induction of the PTEN Tumor Suppressor: Pivotal Roles of the Inhibition of the PTEN Repressors Snail and YY1
Authors: Stavroula Baritaki, Eriko Suzuki, Mario I. Vega, Haiming Chen, James R. Berenson, Benjamin Bonavida
Journal: Blood (2010)
Gene Expression Profiling of Philadelphia Chromosome(Ph) Negative CD34+ Hematopoietic Stem and Progenitor Cells of Patients with Ph Positive CML in Complete Molecular Remission during Therapy with Imatinib.
Authors: Frank Neumann, Nathalie Teutsch, Slawomir Kliszewski, Simone Bork, Benedikt Brors, Nadine Schimkus, Nicole Roes, Ulrich Steidl, Ulrich Germing, Barbara Hildebrandt, Brigitte Royer-Pokora, Roland Eils, Norbert Gattermann, Rainer Haas, Ralf Kronenwett
Journal: Blood (2004)
TH17 Pathway Promotes Tumor Cell Growth and Suppresses Immune Function in Myeloma: Potential for Therapeutic Application
Authors: Rao Prabhala, Dheeraj Pelluru, Mariateresa Fulciniti, Puru Nanjappa, Harsha K. Prabhala, Nithya S. Prabhala, Constantine Mitsiades, Yu-Tzu Tai, Irene Ghobrial, Paul Richardson, Konstantinos Lefkimmiatis, John F. Daley, Yvonne A. Efebera, Kenneth C. Anderson, Nikhil C. Munshi
Journal: Blood (2008)
Role of the Ether-a-gò-gò-Related Gene 1B Isoform in Hematopoiesis
Authors: Serena Pillozzi, Marika Masselli, Marinella Veltroni, Emanuele De Lorenzo, Antonella Fiore, Massimo D'Amico, Henry Duff, Andrea Becchetti, Annarosa Arcangeli
Journal: Blood (2012)
Application of a Short Tandem Repeat Based PCR Assay for Chronological Monitoring of Myelodysplastic Syndrome (MDS) Patients with Deletion of Chromosome 5q Following Lenalidomide Treatment
Authors: Johann-Christoph Jann, Daniel Nowak, Florian Nolte, Stephanie Fey, Verena Nowak, Julia Oblaender, Jovita Pressler, Alice Charlotte Fabarius, Uwe Platzbecker, Aristoteles Giagounidis, Katharina Goetze, Anne Letsch, Detlef Haase, Richard F. Schlenk, Gesine Bug, Michael Luebbert, Arnold Ganser, Ulrich Germing, Claudia Haferlach, Wolf-Karsten Hofmann, Maximilian Mossner
Journal: Blood (2015)
Individualized Tumor Response (ITR) Profiling for Drug Selection in Tailored Therapy: Meta-Analysis of 1929 Cases of Leukemia and Lymphoma.
Authors: Andrew G. Bosanquet, Gertjan J. Kaspers, Rolf Larsson, Robert A. Nagourney, Peter Nygren, Rob Pieters, Peter Staib, Ulf Tidefelt, C. Michel Zwaan, Larry M. Weisenthal
Journal: Blood (2007)
Intensity of 18Fluorodeoxyglucose Uptake in Positron Emission Tomography Is Associated with Unfavorable Prognostic Factors in Untreated Follicular Lymphoma.
Authors: Maria Luigia Vigliotti, Giuseppe Cascini, Ferdinando Frigeri, Anna De Chiara, Paola Della Cioppa, Filomena Oliviero, Secondo Lastoria, Antonio Pinto
Journal: Blood (2005)
Benefits and Harms of Intensive Blood Pressure Treatment in Adults Aged 60 Years or Older
Authors: Jessica Weiss, Michele Freeman, Allison Low, Rochelle Fu, Amy Kerfoot, Robin Paynter, Makalapua Motu'apuaka, Karli Kondo, Devan Kansagara
Journal: Annals of Internal Medicine (2017)

This article has been corrected. The original version (PDF) is appended to this article as a Supplement. Background: Recent guidelines recommend a systolic blood pressure (SBP) goal of less than 150 mm Hg for adults aged 60 years or older, but the balance of benefits and harms is unclear in light of newer evidence. Purpose: To systematically review the effects of more versus less intensive BP control in older adults. Data Sources: Multiple databases through January 2015 and MEDLINE to September 2016. Study Selection: 21 randomized, controlled trials comparing BP targets or treatment intensity, and 3 observational studies that assessed harms. Data Extraction: Two investigators extracted data, assessed study quality, and graded the evidence using published criteria. Data Synthesis: Nine trials provided moderate- to high-strength evidence that BP control to less than 150/90 mm Hg reduces mortality (relative risk [RR], 0.93 [95% CI, 0.85 to 1.00]), cardiac events (RR, 0.83 [CI, 0.71 to 0.96]), and stroke (RR, 0.77 [CI, 0.65 to 0.91]). Six trials overall provide low-strength evidence that lower targets (≤140/85) do not reduce mortality (RR, 0.93 [CI, 0.75 to 1.14]), cardiac events (RR, 0.91 [CI, 0.77 to 1.04]), or stroke (RR, 0.86 [CI, 0.64 to 1.07]). However, there were important inconsistencies across these studies, and one large trial showed targeting SBP less than 120 mm Hg in patients at high cardiovascular risk reduced mortality and cardiac events. Limitation: Data relevant to frail elderly adults and the effect of multimorbidity are limited. Conclusion: Treatment to at least current guideline standards for BP (<150/90 mm Hg) substantially improves health outcomes in older adults. There is less consistent evidence, largely from 1 trial targeting SBP less than 120 mm Hg, that lower BP targets are beneficial for high-risk patients. Lower BP targets did not increase falls or cognitive decline but are associated with hypotension, syncope, and greater medication burden. Primary Funding Source: U.S. Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Quality Enhancement Research Initiative. (PROSPERO 2015: CRD42015017677)
The Evolution and Impact of Subclonal Mutations in Chronic Lymphocytic Leukemia
Authors: Dan-Avi Landau, Scott Carter, Petar Stojanov, Kristen E. Stevenson, Aaron Mckenna, Michael Lawrence, Carrie Sougnez, Andrey Sivachenko, Lili Wang, Wandi Zhang, Shukla Sachet, Alexander R. Vartanov, Stacey M. Fernandes, Kristian Cibulskis, Bethany Tesar, Stacey Gabriel, Matthew Meyerson, Eric S. Lander, Donna S. Neuberg, Jennifer R. Brown, Gad Getz, Catherine J. Wu
Journal: Blood (2012)
Radiation-Induced Angiosarcoma after Breast-Cancer Treatment
Authors: Jennifer K Plichta, Kevin Hughes
Journal: New England Journal of Medicine (2017)

A 72-year-old woman presented with skin changes on her left breast; 5 years earlier, she had undergone lumpectomy and radiation therapy for breast cancer. Examination revealed an area of skin that had an ecchymotic appearance, with no underlying mass or nodular tissue.
PD-L1 protein expression assessed by immunohistochemistry is neither prognostic nor predictive of benefit from adjuvant chemotherapy in resected non-small cell lung cancer
Authors: M.-S. Tsao, G. Le Teuff, F.A. Shepherd, C. Landais, P. Hainaut, M. Filipits, R. Pirker, T. Le Chevalier, S. Graziano, R. Kratze, J.-C. Soria, J.-P. Pignon, L. Seymour, E. Brambilla
Journal: Annals of Oncology (2017)
In Vivo Treatment of AML Patients with High-Dose Simvastatin Inhibits Geranylgeranylation In AML Cells
Authors: Karen van der Weide, Susan D.P.W.M. de Jonge-Peeters, Gerwin A. Huls, Rudolf S.N. Fehrmann, Jan J. Schuringa, Folkert Kuipers, Elisabeth G.E. de Vries, Edo Vellenga
Journal: Blood (2010)
Discovery, Engineering and Pre-Clinical Evaluation of an Anti-vWF A1 Domain Aptamer.
Authors: John L. Diener, H.A. Daniel Lagasse, Madaline Gilbert, Patricia Merlino, Jason Killough, H. Nicholas Marsh, Ryan M. Boomer, Joseph M. Fraone, Thomas McCauley, Ankit Makim, Scott D. Lewis, Larry Cai, Renta Hutabarat, James B. Rottman, Claude Benedict, David Fontana
Journal: Blood (2006)
LEFT VENTRICULAR DYSSYNCHRONY PREDICTS VENTRICULAR TACHYARRHYTHMIAS IN PATIENTS WITH SEVERELY REDUCED LEFT VENTRICULAR SYSTOLIC FUNCTION
Authors: Saurabh Malhotra, Deepak K. Pasupula, Ravi K. Sharma, Samir Saba, David Schwartzman, Prem Soman
Journal: Journal of the American College of Cardiology (2013)
Optical coherence tomography as a method for quantitative skin evaluation in systemic sclerosis
Authors: Natália Sotero Machado Pires, Andréa Tavares Dantas, Angela Luzia Branco Pinto Duarte, Marcello Magri Amaral, Luana Osório Fernandes, Tereza Januária Costa Dias, Luciana Santos Afonso de Melo, Anderson Stevens Leônidas Gomes
Journal: Annals of the Rheumatic Diseases (2017)

Improved, non-invasive techniques for the diagnosis, classification and monitoring of patients with systemic sclerosis (SSc) are needed. One potential technique for quantifying the extent of cutaneous sclerosis in these patients is optical coherence tomography (OCT).1 ,2 Recently, Abignano et al 3 suggested the use of OCT as a feasible and reliable technique to evaluate skin fibrosis in SSc. Based on that initial work, the aim of this study was to evaluate OCT images and compare the findings with the modified Rodnan skin score (mRSS) in patients with SSc.

Thirty-three Brazilian patients with SSc (28 women; mean age 46.1 years; range 19–71 years) were recruited and fulfilled criteria for SSc proposed by American College of Rheumatology (ACR), 19804 or ACR/European League Against Rheumatism, 2013.5 Patients were classified into limited SSc (n=18) and diffuse SSc (n=15) groups. The mean disease duration was 9.7 years (median 8 years, range 2–26 months). Thirty-five healthy control (HC) (28 women, …
Clofarabine (CLO) Is Active in Patients (pts) with Refractory and/or Relapsed Non-Hodgkin’s Lymphoma (NHL): A Phase I/II Study.
Authors: Chadi Nabhan, Walter Fried, Angel G. Galvez, Parameswaran Venugopal, Phillip Gozun, Jacob D. Bitran
Journal: Blood (2007)
Eligibility Criteria Are Not Associated with Expected or Observed Adverse Events in Randomized Controlled Trials (RCTs) of Hematologic Malignancies
Authors: Abby Statler, Tomas Radivoyevitch, Caitlin Siebenaller, Aaron T. Gerds, Matt Kalaycio, Eric Kodish, Sudipto Mukherjee, Connie Cheng, Mikkael A. Sekeres
Journal: Blood (2015)
In Vitro Characteristics, Anticoagulant Effects and In Vivo Antithrombotic Efficacy of a Novel, Potent and Orally Active Direct Factor Xa Inhibitor, DU-176b.
Authors: Yoshiyuki Morishima, Taketoshi Furugohri, Koji Isobe, Yuko Honda, Chikako Matsumoto, Yoko Shiozaki, Sumie Muramatsu, Nobutoshi Sugiyama, Toshiro Shibano
Journal: Blood (2004)
Facilitating Engraftment After MHC-Matched, Allogeneic BMT by IL-2 / Anti IL-2 Complex Treatment Requires Targeting CD25 On, and Activation in Situ of, Residual CD4 Tregs.
Authors: Alwi Shatry, Michael A Gorin, Jackelin G Chirinos, Robert B. Levy
Journal: Blood (2009)
CD34+ Cells in Bone Marrow Are Quantitatively and Functionally Impaired in Patients with Poor Graft Function Following Allogeneic Hematopoietic Stem Cell Transplantation
Authors: Yuan Kong, Yue Hu, Yuan-yuan Zhang, Yu-Hong Chen, Wei Han, Xiao-Hui Zhang, Lan-Ping Xu, Xiao-Jun Huang
Journal: Blood (2014)
Genetic Disparity between Stem Cell Transplant Patients and Their Donors Assessed by High Density Single Nucleotide Polymorphism (SNP) Microarray Typing Is Seen in Specific Genomic Regions.
Authors: Ephraim P. Hochberg, David Miklos, Emmanuel Zorn, Jesse Levin, Carol Reynolds, Christine Canning, Robert J. Soiffer, Jerome Ritz
Journal: Blood (2004)
VTD (Bortezomib Plus Thalidomide Plus Dexamethasone) Followed By Autologous Stem Cell Transplantation As First Line Treatment for Multiple Myeloma: Real Life Results from a Single Institution
Authors: Salvatore Palmieri, Angela Gravetti, Stefano Rocco, Antonella Carbone, Carolina Copia, Giuseppe Monaco, Cira Riccardi, Fioravante Ronconi, Felicetto Ferrara
Journal: Blood (2015)
High-Dose Cyclophosphamide (Cy), Rituximab, and a Cancer Vaccine for Relapsed Classical Hodgkin's Lymphoma (cHL)
Authors: Yvette L. Kasamon, Richard J. Jones, Hyam I. Levitsky, Ivan M. Borrello, M. Victor Lemas, Michael J. Borowitz, Lode J. Swinnen, Richard F. Ambinder
Journal: Blood (2010)
Lineage-Specific Transcriptional Regulation of GATA1 Is Dependent on Lineage-Specific Utilisation of Multiple Cis-Elements and Haematopoietic Transcription Factors.
Authors: Paresh Vyas, Boris Guyot, Veronica Valverde-Garduno, Eduardo Anguita, Isla Hamlett, Catherine Porcher
Journal: Blood (2004)
Toll-Like Receptor Signaling Pathway In Chronic Lymphocytic Leukemia: Distinct Gene Expression Profiles of Potential Pathogenetic Significance In Specific Subsets of Patients
Authors: Eleni Arvaniti, Stavroula Ntoufa, Nikos Papakonstantinou, Tasoula Touloumenidou, Nikolaos Laoutaris, Achilles Anagnostopoulos, Kleoniki Lamnisou, Federico Caligaris-Cappio, Kostas Stamatopoulos, Paolo Ghia, Marta Muzio, Chrysoula Belessi
Journal: Blood (2010)
Co-Existence of Various Sub-Clones in TEL-AML1 Positive Acute Lymphoblastic Leukemia in Association with Sub-Microscopic Deletion of AML1.
Authors: Amos Toren, Rachel Rothman, Bella Bielorai, Malka Reichart, Ninette Amariglio, Gideon Rechavi, Luba Traktenbrot
Journal: Blood (2004)
A Wearable Hydration Sensor with Conformal Nanowire Electrodes
Authors: Shanshan Yao, Amanda Myers, Abhishek Malhotra, Feiyan Lin, Alper Bozkurt, John F. Muth, Yong Zhu
Journal: Advanced Healthcare Materials (2017)

A wearable skin hydration sensor in the form of a capacitor is demonstrated based on skin impedance measurement. The capacitor consists of two interdigitated or parallel electrodes that are made of silver nanowires (AgNWs) in a polydimethylsiloxane (PDMS) matrix. The flexible and stretchable nature of the AgNW/PDMS electrode allows conformal contact to the skin. The hydration sensor is insensitive to the external humidity change and is calibrated against a commercial skin hydration system on an artificial skin over a wide hydration range. The hydration sensor is packaged into a flexible wristband, together with a network analyzer chip, a button cell battery, and an ultralow power microprocessor with Bluetooth. In addition, a chest patch consisting of a strain sensor, three electrocardiography electrodes, and a skin hydration sensor is developed for multimodal sensing. The wearable wristband and chest patch may be used for low-cost, wireless, and continuous monitoring of skin hydration and other health parameters.
The Importance of the Baby-Friendly Hospital Initiative
Authors: Debi Ferrarello
Journal: JAMA Pediatrics (2017)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Pediatrics HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Pediatrics journal
A Phase I Study of the Combination of Decitabine with Lenalidomide for Patients with High Risk (IPSS Int-2 or High) Myelodysplastic Syndrome
Authors: Carlos Manuel de Castro, Donna Adams, Arati V Rao, Joseph O. Moore, Jon P. Gockerman, Louis F. Diehl, Anne W Beaven, Julie Warzecho, David A. Rizzieri
Journal: Blood (2011)
Reply from Authors re: Emmanuel S. Antonarakis, Howard I. Scher. Do Patients With AR-V7–Positive Prostate Cancer Benefit from Novel Hormonal Therapies? It All Depends on Definitions. Eur Urol 2017;71:4–6
Authors: Julie Steinestel, Christof Bernemann, Andres J Schrader, Jochen K Lennerz
Journal: European Urology (2016)
Therapeutic Effect of CXCR3-Expressing Regulatory T Cells on Liver and Intestinal Damages in a Murine Acute GVHD Model.
Authors: Jun Yamanouchi, Hitoshi Hasegawa, Atsushi Inoue, Masashi Kohno, Hiroshi Fujiwara, Takaaki Hato, Masaki Yasukawa
Journal: Blood (2007)
Reduced-Intensity Cord Blood Transplantation in Adult Patients for the Recurrence after Allogeneic Transplantation.
Authors: Sachiko Seo, Naoyuki Uchida, Hisashi Yamamoto, Naofumi Matsuno, Yoshiko Matsuhashi, Shinsuke Takagi, Daisuke Kato, Kazuhiro Masuoka, Atsushi Wake, Shigesaburo Miyakoshi, Shuichi Taniguchi
Journal: Blood (2006)
Dysregulation of the Imprinted DLK1-DIO3 Locus in Promyelocytic Leukemia
Authors: Maria Trissal, David H Spencer, Jessica Silva, Todd Wylie, Jasreet Hundal, Sean McGrath, Vincent Magrini, Giridharan Ramsingh, Richard J Wilson, Timothy J. Ley, Daniel C. Link
Journal: Blood (2012)
Clofarabine (Clo) +/− Fludarabine (Flu) with IV Busulfan (Bu) and Allogeneic Stem Cell Transplantation (Allo-SCT) for Relapsed, Refractory Myeloid Leukemia (ML) and MDS
Authors: Borje S. Andersson, Marcos de Lima, Laura L. Worth, Uday Popat, Roy B. Jones, Elizabeth J. Shpall, Chitra Hosing, Timothy Madden, Reza Kazerooni, Patricia McAdams, Amin Alousi, Partow Kebriaei, Richard E. Champlin
Journal: Blood (2008)